BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹172 Cr | ₹157 Cr | ₹193 Cr | ₹233 Cr | ₹204 Cr |
What is the latest Total Current Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹172 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹193 Cr |
| Mar2022 | ₹233 Cr |
| Mar2021 | ₹204 Cr |
How is Total Current Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹172 Cr | 9.09 | |
| Mar2024 | ₹157 Cr | -18.55 | |
| Mar2023 | ₹193 Cr | -17.09 | |
| Mar2022 | ₹233 Cr | 14.46 | |
| Mar2021 | ₹204 Cr | - | |
Compare Total Current Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,713.4 Cr | -1.4% | -9.6% | -10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -1.4% |
-9.6% |
-10.9% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses